This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Kelly, D. J Articles by Gilbert, R. E Search for Related Content PubMed PubMed Citation Articles by Kelly, D. J Articles by Gilbert, R. E Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB STREPTOZOTOCIN Social Bookmarking                         What's this?

Cells expressing the stem cell factor receptor, c-kit, contribute to neoangiogenesis in diabetes

University of Melbourne, Department of Medicine, St Vincent's Hospital, Fitzroy, Victoria, Australia

Yuan Zhang

University of Melbourne, Department of Medicine, St Vincent's Hospital, Fitzroy, Victoria, Australia

Renae M Gow

University of Melbourne, Department of Medicine, St Vincent's Hospital, Fitzroy, Victoria, Australia

Silviu Itescu

University of Melbourne, Department of Medicine, St Vincent's Hospital, Fitzroy, Victoria, Australia

Richard E Gilbert

University of Melbourne, Department of Medicine, St Vincent's Hospital, Fitzroy, Victoria, Australia

While neoangiogenesis in diabetes is of greatest clinical significance in the retina, the pathological formation of new blood vessels also develops in other vascular beds in diabetes, including the mesentery of the streptozotocin-induced diabetic rat. However, the contribution of bone marrow-derived cells to this process of vasculogenesis is unknown.

In this study, male Sprague-Dawley rats were randomised to receive either streptozotocin or vehicle, and their mesenteric vasculature was examined after three weeks. Origins from bone marrow and endothelial cell differentiation were identified by immunolabelling for the stem cell factor receptor, c-kit and von Willebrand factor (vWF), respectively. Expression for the angiogenic chemokine, stromal derived factor-1 (SDF-1) was assessed by quantitative real-time polymerase chain reaction (PCR).

At three weeks, rats with diabetes had a dramatic (190-fold) increase in lectin-labelled blood vessel profiles in the mesenteric bed (p<0.0001) in association with a five-fold increase in SDF-1 mRNA (p<0.01). Immunohistochemical studies identified abundant large, ovoid, lumen-forming, c-kit⁺ cells in the mesentery of diabetic, but not control, rats. Many of these c-kit⁺ cells also showed positive immunolabelling for vWF, consistent with endothelial differentiation.

In conclusion, cells of bone marrow origin contribute to new vessel formation in the diabetic mesentery. This phenomenon may also apply to the neovascularisation that develops at clinically important sites such as in the retina.

Key Words: diabetes • stem cell factor • stromal derived factor • neoangiogenesis • mesentery

Diabetes and Vascular Disease Research, Vol. 2, No. 2, 76-80 (2005)
DOI: 10.3132/dvdr.2005.013


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?